Back to News
Market Impact: 0.65

Why this stock remains JPMorgan’s top pick in the U.K. market?

JPMIMI
Company FundamentalsAnalyst InsightsCorporate EarningsCorporate Guidance & OutlookM&A & RestructuringCapital Returns (Dividends / Buybacks)
Why this stock remains JPMorgan’s top pick in the U.K. market?

J.P. Morgan has reaffirmed IMI as its top U.K. stock pick, citing significant operational improvements since 2019, including higher margins and EPS growth, which are currently mismatched with a substantial valuation discount relative to peers. The bank raised its price target to 2,850p, implying 27% upside, noting that a potential sale of the Transport division could unlock further value and enhance portfolio quality. Strong free cash flow generation, forecast to exceed £1 billion between 2025-2027, and recovering end markets are expected to provide additional catalysts, underscoring IMI's compelling investment case despite current undervaluation.

Analysis

J.P. Morgan has reiterated IMI as its top U.K. stock pick, highlighting a significant disconnect between the company's improved operational performance and its current market valuation. Since 2019, IMI has delivered an average annual adjusted EPS growth of approximately 11% and expanded operating margins to 19.7% in 2024, with forecasts for margins to exceed 21% by 2027. Despite these fundamental strengths, the company's valuation has de-rated, now trading at a 27% discount to peers on an EV/EBIT basis and a 35% discount on a P/E basis, substantially wider than its historical averages of 10% and 17%, respectively. J.P. Morgan identifies several key catalysts that could unlock this value, including the potential sale of its Transport division, which is under strategic review. A disposal is viewed as the optimal outcome, potentially unlocking 34% upside to a fair value of 3,010p and funding shareholder returns equivalent to 4% of market capitalization. Further upside is supported by expected recoveries in its Climate Control, Industrial Automation, and Life Sciences end markets, which would diversify earnings away from the currently dominant Process Automation division. The bank also notes that investor concerns regarding oil and gas exposure are overstated, with only 12.5% of Process Automation revenue tied to the sector. Lastly, robust free cash flow, projected to surpass £1 billion between 2025 and 2027, provides significant optionality for capital allocation, with scope for share buybacks of around 11% of market capitalization or M&A activity up to 17%.